CGH and OCC Announce a New, Two-Year Funding Opportunity for NCI-designated Cancer Centers
, by Shannon Silkensen
I believe in partnerships; people helping people to attain shared goals and better health. That’s what attracts me to global health and, specifically, cancer control and prevention. What can we do together to prevent and control this disease that devastates individuals, families, and communities?
CGH staff work every day to answer this question. Through programs, collaborations, and opportunities, CGH strives to unite the cancer community to advance international efforts in cancer control and prevention. Today I’m excited to announce a new funding opportunity available from CGH for cancer prevention and control (CPC) researchers at NCI-designated cancer centers: Administrative Supplements to Promote Cancer Prevention and Control Research in Low and Middle Income Countries.
CGH has partnered with the NCI, Office of Cancer Centers to design a two-year administrative supplement to promote the development of new, or strengthen ongoing, partnerships between investigators at NCI-designated cancer centers and foreign institutions in low- and middle-income countries (LMICs). In addition, the supplements seek to support teams of researchers gathered to address the CPC needs of LMIC populations, while facilitating knowledge sharing between US and foreign investigators.
Administrative Supplements to Promote Cancer Prevention and Control Research in Low and Middle Income Countries support a single CPC-focused pilot project. Topics of particular interest include:
- Clinical and translational research;
- Detection and diagnosis of cancer, including anatomic and clinical pathology;
- Health surveillance including cancer registries and death registries;
- Knowledge sharing;
- Implementation science;
- Informatics and mHealth;
- HIV-associated malignancies; or
- Malignancies associated with chronic infection.
It is my hope, that the findings from these pilot projects will improve cancer prevention and control strategies both in the US and abroad, and that the partnerships forged between the investigators will last a lifetime.